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ABSTRACT
Human Bex2 (brain expressed X-linked, hBex2)i s
highly expressed in the embryonic brain, but its
function remains unknown. We have identified that
LMO2, a LIM-domain containing transcriptional fac-
tor, specifically interacts with hBex2 but not with
mouseBex1andBex2.Theinteractionwasconfirmed
both by pull-down with GST-hBex2 and by
coimmunoprecipitationassaysinvivo.Usingelectro-
phoretic mobility shift assay, we have demonstrated
the physical interaction of hBex2 and LMO2as part of
a DNA-binding protein complex. We have also shown
that hBex2 can enhance the transcriptional activity of
LMO2 in vivo. Furthermore, using mammalian two-
hybrid analysis, we have identified a neuronal bHLH
protein, NSCL2, as a novel binding partner for LMO2.
WethenshowedthatLMO2couldup-regulateNSCL2-
dependent transcriptional activity, and hBex2 aug-
mented this effect. Thus, hBex2 may act as a specific
regulatorduringembryonicdevelopmentbymodulat-
ing the transcriptional activity of a novel E-box
sequence-binding complex that contains hBex2,
LMO2, NSCL2 and LDB1.
INTRODUCTION
Interactions among transcriptional factors provide molecular
mechanisms for the highly regulated temporal and spatial
gene expression during embryonic development. Importantly,
unveiling the function of a novel gene often relies on
identifying its interactions with proteins of known function.
We have identiﬁed a group of genes speciﬁcally expressed in
human fetal brains (1) including human Bex2 (previously
reported as human Bex1), a previously reported brain-
expressed, X-linked protein of unknown function (2). The
Bex gene family is composed of at least six members:
Bex1/Rex3/EG2RVC/NADE4, Bex2, Bex3/NADE/HGR74
and three new Bexs,Bex4/5/6(2–6).Twoadditional Bex ortho-
logs, NADE2 and NADE3, were reported to be only expressed
in human (7). Recently, the nomenclature for human Bex1 and
Bex2 was revised since the previously designated human Bex1
has higher sequence identity with mouse Bex2 than with
mouse Bex1 (74 and 68% identity, respectively) (8). With
this revision in the nomenclature, the localization of
Bex1–4 on the X chromosome from three species—human,
rat and mouse—matches within the cluster (2,8). It has been
shown that mouse Bex1 is transiently expressed during early
development at the 2–8 cell stage, and then again expressed at
the blastocyst stage (9). Murine Bex1 has also been suggested
to play a role in neural development. For example, the expres-
sion of Bex1 was suppressed in F9 cells and PC12 cells upon
retinoic acid or NGF treatment, respectively (4,10). Rat Bex1
was reported as one of the most commonly identiﬁed genes in
asubtractive screenforventralmesencephalicgenesexpressed
at E10 (8). Additionally, the high expression proﬁle of Bex1/2
in the adult brain supports a role of both proteins in the neural
activity in mature neurons (2,6,8). However, the molecular
mechanisms by which Bex proteins are involved in
neurodevelopment remain elusive. Interestingly, both Bex1
and Bex2 were recently identiﬁed as binding partners for
olfactory marker protein (OMP), a soluble protein possibly
involved in olfactory signal transduction (11,12). Despite its
interaction with OMP, Bex2’s broader expression in the brain
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broader functional role in the brain (6). Moreover, mBex3,
which has a relatively weaker sequence similarity with
Bex1/2, was observed to interact with p75NTR in inducing
apoptotic cell death (NADE) (5,7). Thus, the Bex family may
play a dual role at the transcriptional and cytoplasmic signal-
ing levels during embryonic development.
To determine the molecular and cellular mechanisms under-
lying the function of human Bex2 (previously named Bex1)
(13), we have used a yeast two-hybrid system to screen for
interacting proteins of hBex2, and identiﬁed LMO2 as a bind-
ing protein. LMO2, a member of the LIM-only class proteins
and formerly named rhombotin-2 (rbtn-2 or Ttg-2), has been
extensively reported to play a role in hematopoietic stem cell
differentiation (14,15). The Drosophila homolog of LMO,
dLMO, was also indicated in an evolutionarily conserved
mechanism involved in patterning appendages (16). Interest-
ingly, recent evidence indicates that dLMO controls the
responsiveness of PDF-expressing ventral lateral neurons
(principle circadian pacemaker cells) to cocaine, which in
turn regulate the behavioral sensitivity of the ﬂies to the
drug (17). Furthermore, one of its distant relatives, LMO4,
has been suggested to play a role in neurogenesis and neuro-
degenerative disease (18–20). As a highly expressed protein in
the brain (21,22), LMO2 has been reported to be expressed in
the hippocampus during development (23). This expression is
up-regulated during seizure-induced responses, suggesting a
role in neuronal regeneration after epileptic pathogenesis (24).
We next examined whether NSCL2, a neuronal form of
Class II bHLH protein SCL, can interact with LMO2. It has
been reported that LMO2 may interact with NSCL1 as an
adaptor in addition to other transcription factors (25–27).
However, this interaction failed to show direct regulation of
transcriptional activity in a previous report (25). Here we have
shown the functional interaction between LMO2 and NSCL2,
suggesting the existence of a novel complex that is composed
of hBex2, LMO2, NSCL2 and LDB1. The unveiling of this
complex may help to understand the molecular mechanisms
by which hBex2 plays a role in transcriptional regulation in the
brain during neurodevelopment.
MATERIALS AND METHODS
cDNA plasmid construction
The full-length cDNAs for hBex1, hBex2, hBex3(NADE),
mBex1, mBex2, mBex3 and various deletion mutants of
hBex2 used in the yeast two-hybrid assay were cloned in
frame with the GAL4 DNA-binding domain into vector
pAS2-1 (BD_Clontech, CA). The Genbank accession
numbers for the various Bex genes are: hBex1, AF251053
(for nomenclature change see Introduction); hBex2,
AF237783; hBex3(NADE), AF187064; mBex1, AF097438;
mBex2, AF097439; mBex3 and AF097440. The GAL4 AD
fused LMO2 expressing plasmid was generated by inserting
the LMO2 cDNA into pACT2 (BD Clontech, CA). The GST
fusion protein constructs (pGEX-hBex2 and pGEX-LMO2)o f
hBex2 and LMO2 were constructed by in-frame insertion of
hBex2 and LMO2 cDNAs into pGEX4T-1 and pGEX6P-1
(Amersham Pharmacia Biotech, Piscataway, NJ). hBex2-
EGFP was constructed by in-frame insertion of the hBex2
cDNA with leading Kozak sequence into pEGFP-N1 vector
(BD Clontech, CA). The chimeric constructs between hBex2
(H) and mBex1 (m) (mHm and HmH) were subcloned into
pMRFP containing a monomer red ﬂuorescent protein
(R. Tsien, UCSD). pcDNA-LMO2 was constructed by insert-
ing the LMO2 cDNA with leading Kozak sequence into
pcDNA 3.1(+) vector. The same cDNA was used in construct-
ing EGFP fused LMO2 expression plasmid pEGFP-LMO2.
The PM3 (BD Clontech), PM3-LMO2, PM3-NSCL1 and
PM3-NSCL2 are SV40 promoter-driven vectors expressing
Gal4BD fused proteins. VP16 (BD Clontech), VP16-NSCL1
and VP16-NSCL2 are plasmids expressing VP16 fused pro-
teins. The wild-type E-box-luciferase and the mutant form of
E-box-luciferase were generated from pGAL-luc and were
obtained as kind gifts from Dr Hakan Axelson.
Yeast two-hybrid screen
The full-length Bex2 was used as bait to screen a human fetal
brain cDNA library as described in the user manual for the
MATCHMAKER yeast two-hybrid system 2 (BD Clontech,
CA). Yeast colonies with potential positive interactions were
further tested for LacZ activity and survival on selective
media. Plasmids containing cDNA for interacting proteins
were extracted from the positive yeast clones and further
sequenced with pACT2 speciﬁc primers.
Cell culture and transfection
All cells were maintained in 5% CO2 at 37 C in medium
containing penicillin and streptomycin unless otherwise
noted. HeLa and COS7 cells were maintained in DMEM
(Invitrogen) with 10% cosmic calf serum (Hyclone, Logan,
UT) and 2 mM L-glutamine, 1 mM sodium pyruvate and
0.1 mM nonessential amino acids. For transfection, cells
were ﬁrst plated on poly-D-lysine and Matrigel double-
coated glass coverslips in a 24-well dish in culture medium
without antibiotics the day before transfection. Cells on cover-
slips were then transfected by using LipofectAMINE 2000
according to the manufacturer’s instructions (Invitrogen,
San Diego, CA). After 12 h, transfected cells were ﬁxed for
immunoﬂuorescence.
GST fusion protein and antiserum generation
pGEX-hBex2 and pGEX-LMO2 plasmids were transformed
into Escherichia coli strain BL21(DE3). The protein expres-
sion and puriﬁcation were performed according to the manu-
facturer’s user manual (Amersham Pharmacia Biotech,
Piscataway, NJ). Two New Zealand white female rabbits
were immunized with 600 mg puriﬁed protein in complete
Freund’s adjuvant (Sigma, St Louis, MO) and were boosted
three times with 300 mg protein in incomplete Freund’s adjuv-
ant at 3 week intervals. The titer and speciﬁcity of antisera
were then determined by ELISA after each boost until the titer
reached 1:1 · 10
6. The antisera were further tested by western
blot against either the recombinant or expressed proteins.
GST fusion protein mediated pull-down assay
GST or GST-hBex2 fusion protein was expressed in E.coli
strain BL21(DE3) and puriﬁed with Sepharose CL-4B resin
(Amersham Pharmacia Biotech, Piscataway, NJ). The cell
lysates from either pEGFP- or pEGFP-LMO2-transfected
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bound resin at 4 C for 4 h. The pellets were washed three
times with phosphate-buffered saline (PBS), separated by 10%
SDS–PAGE and analyzed with western blot.
Immunofluorescent microscopy
HeLa cells transfected with the FLAG-tagged hBex2 and
pEGFP-LMO2 were grown on 25 mm glass coverslips. The
cells were ﬁxed with 4% PFA and permeabilized with 0.1%
Triton X-100 in PBS (pH 7.4). Cells were then incubated with
anti-FLAG antibody (M2, Sigma, St Louis, MO), followed by
incubation with TRITC conjugated secondary antibody. Con-
focal microscopic analysis was performed as described previ-
ously (28).
Electrophoretic mobility shift assay (EMSA)
EMSAs were performed with
32P-labeled double-strand
oligonucleotides as described previously (29). Oligonuc-
leotides containing the E-box motif (underlined sequences)
were synthesized as follows: 50-CTGGCTAGCGGGTCG-
CAGCTGCGTCCCGGGTCGCAGCTGCGTCCCGGGTCG-
CAGCTGCGTCCCCTCGAGATC-30 and 50-GATCTCGAG-
GGGACGCAGCTGCGACCCGG GACGCAGCTGCGACC-
CGGGACGCAGCTGCGACCCGCTAGCCAG-30 (under-
lined is the hexameric sequence of E box). Nuclear extracts
from M17 cells were prepared and incubated with labeled
oligonucleotide for 20 min at room temperature, followed
by incubation with pre-immune serum, anti-LMO2 anti-
serum or anti-hBex2 anti-serum. The gel was dried, exposed
to Kodak ﬁlm overnight and then processed.
Transfection of cDNA plasmid into mammalian cells
and luciferase assay
Cos-7 cells growing in 12-well plates with 90% conﬂuence
were transfected with 1 mg cDNA plasmid per well using
LipofectAMINE 2000 as described in the manufacturer’s
user manual (Invitrogen, Carlsbad, CA). After 24 h, cell
extracts were prepared and luciferase reporter assays were
performed using the Dual-Luciferase Reporter Assay System
(Catalog no. E1910, Promega, Madison, WI). The luciferase
activity was measured using the LB9507 Luminometer
(EG&G Berthold, Wellesley, MA). The transcriptional activ-
ity of the reporter gene was measured by relative luciferase
activity value, which is the value of ﬁreﬂy luciferase activity
divided by the value of renilla luciferase activity.
Coimmunoprecipitation
Fetalbraintissue(50g)washomogenizedin250mlofbufferA
[10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EGTA, 0.5 mM
phenylmethlysulfonyl ﬂuoride (PMSF), 1 mM DTT, and
10 mg/ml for each of the following protease inhibitors: leu-
peptin, aprotinin and pepstatin]. The homogenate was then
treated with NP-40 (0.2% ﬁnal) for 15 min on ice and cent-
rifuged for 15 min at 15000 g,4  C. The nuclear pellet was
resuspended in 20 ml of buffer B (10 mM HEPES, pH 7.9,
0.1 mM EGTA, 0.4 M NaCl, 0.5 mM PMSF, 1 mM DTT and
protease inhibitors) and incubated with rotation at 4 C for
15 min. The extract was then centrifuged, and the supernatant
was dialyzed against 500 ml of buffer C (10 mM Tris–HCl,
pH 7.9, 120 mM NaCl, 0.3% NP-40, 0.25% BSA and 1 mM
DTT) at 4 C. Nuclear extracts ( 100 mg protein) were
incubated with polyclonal anti-hBex2, anti-LDB1 or control
antisera for 6 h at 4 C. The complexes were precipitated with
protein A or G agarose, washed four times in RIPA buffer
(50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1%
Nonidet P-40, 1% deoxycholate and 0.1% SDS), and then
detected by western blot using antisera a-LMO2 (Santa
Cruz Biotechnology, Santa Cruz, CA) or a-NSCL2, (CeMines,
Inc., Golden, CO), as indicated.
RESULTS
Identification of LMO2 as an interacting partner
for hBex2
To gain insight into the function of hBex2 in development,
we used a human fetal brain cDNA library in a Gal4 yeast
two-hybrid system (BD Clontech, CA) to identify interact-
ing proteins. Using the full-length hBex2 as bait, we
screened  1 · 10
7 transformants and acquired  59 His and
b-galactosidase positive yeast colonies. Following cDNA
plasmid extraction and sequencing analysis, we chose to
focus on a candidate cDNA clone corresponding to the com-
plete coding sequence of LMO2, a LIM containing a transcrip-
tional regulator involved in neurogenesis (24). The interaction
between two proteins was further veriﬁed by retransformation
into yeast strain SFY-526 to exclude the possibility of a false
positive as a result of self-activation.
To determine the speciﬁcity of the interaction between
LMO2 and hBex2 in the yeast two-hybrid system, we tested
whether LMO2 could interact with other members of the Bex
family, including hBex3, mBex1, mBex2 and mBex3. For a
positive control, we also used the TAX protein of human
T-cell leukemia virus type1 because of its self-association
(28) (Table 1). Among the ﬁve Bex homolog genes tested
in the yeast Gal4-BD construct, only hBex2 interacted with
LMO2 (Table 1). More speciﬁcally, although it shares 74%
amino acid sequence identity with hBex2 (Figure 1), mBex2
failed to show its interaction with LMO2 in our assay. Sim-
ilarly, mBex1 also showed no interaction with LMO2 although
it also shares high sequence identity (68%) with hBex2. Thus,
the interaction of human Bex2 and LMO2 might be a human
species-speciﬁc event.
To identify the binding domain within hBex2 responsible
for interaction between hBex2 and LMO2, we generated
Table 1. Identification of LMO2 as an interaction partner for hBex2
AD plasmid BD plasmid Result
pAS2-1-TAX pACT2-TAX +
pAS2-1 pACT2  
pAS2-1 pACT2-LMO2  
pAS2-1-hBex2 pACT2  
pAS2-1-hBex2 pACT2-LMO2 +
pAS2-1-hBex3 pACT2-LMO2  
pAS2-1-mBex1 pACT2-LMO2  
pAS2-1-mBex2 pACT2-LMO2  
pAS2-1-mBex3 pACT2-LMO2  
GAL4 yeast two-hybrid system was used to evaluate the interaction of genes
in the Bex family with LMO2. TAX protein of human T-cell leukemia virus
type 1 was used as a positive control. The interactions of listed GAL4–BD
and GAL4–AD fusion pairs were indicated only as positive or negative for
b-galactosidase activity tested in the yeast strain SFY526.
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two-hybrid analysis. As shown in Figure 1A, members of
the Bex family share sequence similarity mainly in the middle
(58% identity) and C-terminal (95% identity) regions. Indic-
ated by the yeast two-hybrid assay, the N-terminal region with
relatively lower sequence similarity between hBex2 and
mBex1 (1–26 amino acid sequence, 48% identity) was not
required for binding to LMO2, nor was the C-terminal region
(88–125), which shares high sequence homology among
Bex family members (Figure 1C). In contrast, all constructs
Figure 1. (A) Multiple alignment of members of the Bex family. The C-terminals of the Bexs (hBex2 88–125) are conserved throughout the family, and the last 12
amino acids (114–125) are identical. hBex2 shares 74% amino acid sequence identity with mBex2 and 68% identity with mBex1.( B) Schematic diagram of hBex2
deletion constructs that were tested for interaction with LMO2 in yeast two-hybrid assay. hBex2 can be divided into three regions according to similarity analysis
amongmembersoftheBexfamily:theN-terminallowhomologregion(1–25),themiddlemediumhomologregion(25–88)andtheC-terminalhighhomologregion
(88–125). Deletion mutations were constructed accordingly. (C) Mapping of the LMO2-binding domain in hBex2. The interactions of the truncation mutation of
hBex2withfull-lengthLMO2wereexaminedbyab-galactosidaseactivityassayintheyeasttwo-hybridsystem.mHmindicatesthechimericconstructcontainingthe
middlepartofhumanBex2flankedbyN-andC-terminiofmouseBex1.TheTAXgenewasalsoincludedasapositivecontrol.Theplussymbolindicatesthepositive
binding between the transformed constructs.
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strong interaction (Figure 1C). However, the middle-region
fragment alone does not bind to LMO2, suggesting that the
sequence itself is insufﬁcient for the binding. Interestingly,
the chimeric mBex1 containing a swapped middle fragment
(26–88) of hBex2 (mHm) showed positive interaction with
LMO2(Figure 1C), further supporting the speciﬁc requirement
of this fragment within the hBex2 sequence for protein–protein
interaction.
Protein–protein interaction between hBex2 and LMO2
To further characterize the interaction between hBex2 and
LMO2, we performed GST pull-down assays. GST and
GST-hBex2 fusion proteins were used to test their interaction
with EGFP-tagged LMO2 from cell extracts from transiently
transfected HeLa cells. As shown in Figure 2A, EGFP-LMO2
bound to GST-hBex2 (lanes 3) but not to GST alone, as indic-
ated by the antibody to the LMO2 fusion protein (lanes 2). We
further tested whether human Bex2 interacts with LMO2
in vivo. As shown in Figure 2B, both proteins were expressed
in human fetal brain extracts. Coimmunoprecipitation of
hBex2 and LMO2 from these extracts using anti-hBex2 Ab
indicates that their interaction may occur during development
(Figure 2C).
Nuclear colocalization of hBex2 and LMO2
LMO2 is localized to the nucleus to play a role in transcrip-
tional regulation (22). The interaction of hBex2 with LMO2
suggests their subcellular colocalization in the nucleus. Con-
sistent with this prediction, evidence suggests that hBex2’s
nuclear export sequence (NES) may be insufﬁcient for trans-
porting the protein out of the nucleus (7). However, it has been
suggested that hBex2 has a cytoplasmic localization pattern
when it is overexpressed in HEK293 cells (8). To clarify this
issue, we examined the subcellular localization of both endo-
genous and overexpressed hBex2 and LMO2 in cell lines. As
Figure 2. Interaction between hBex2 and LMO2 in vitro and in vivo.
(A)pEGFP-LMO2orpEGFP(shortforpEGFP–LMO2lysateorpEGFPlysate)
weretransientlyexpressedinHeLacells.Celllysateswereusedtoperformpull-
downassaybyincubatingwithGST-hBex2orGSTboundtoglutathionebeads.
Western analysis was performed with anti-GFP antibody. Lane 1, pEGFP-
LMO2 cell lysate only; lane 2, GST pull-down from pEGFP-LMO2 lysate;
lane 3, GST-hBex2 pull-down of pEGFP-LMO2 lysate; lane 4, pEGFP cell
lysate only; lane 5, GST-hBex2 pull-down of pEGFP lysate. (B) Endogenous
expressionofhBex2andLMO2inhumanfetalbraintoconfirmthespecificityof
the antibodies. (C) Interaction of hBex2 and LMO2 in human fetal brain tissue.
The fetal brain tissue was used to immunoprecipitate the human Bex2 with a
polyclonal Ab. Precipitate was blotted with an anti-LMO2 Ab.
Figure 3. Nuclear colocalization of hBex2 and LMO2.( A) Endogenous Bex2
andLMO2werecolocalizedinthenucleiofM17cellsusingspecificantibodies
for immunofluorescent staining. (B) FLAG-tagged hBex2 and dsRed-LMO2
were colocalized in the transient transfected HeLa cells. Anti-FLAG mAb
and TRITC-conjugated secondary anti-mouseantibody were used sequentially
to detect the expression of hBex2. The staining image was collected with a
60· objective. (C) Same as (B) with a 20· objective. Bars indicate 10 mm.
Nucleic Acids Research, 2005, Vol. 33, No. 20 6559shown in Figure 3, the endogenous Bex2 and LMO2 were
primarily colocalized in the nuclei of human neuroblastoma
M17 cells by double immunoﬂuorescent staining. Similarly,
the heterogeneously expressed FLAG-hBex2 and dsRed-
LMO2 were also colocalized in the nuclei of transient trans-
fected HeLa cells (Figure 3B). The nuclear localization of
either protein does not seem to be facilitated by the overex-
pression of their binding partners (Figure 3C).
hBex2 increases the transcriptional
activity of LMO2
Previous studies have suggested that LMO2 can form a DNA-
binding complex mediated by the E-box sequence within
Class II bHLH transcription factors (29,30). We speculated
that hBex2 might be involved in the complex formation and
playaroleintranscriptionalregulation.Totestthishypothesis,
we performed EMSAs using a polyclonal antiserum against
LMO2 and hBex2. As shown in Figure 4A, we found that anti-
hBex2 antibody could generate a super-shift band similar to
that seen in the lane with anti-LMO2 antibody. These data
indicate that hBex2 participates in the formation of a
LMO2/E-box complex without interfering in the interaction
of LMO2 with other members of the complex that bind to
the E-box motif. Furthermore, when the recombinant hBex2
was used in the assay, it clearly blocked the shift in a
concentration-dependent manner (Figure 4B), supporting the
speciﬁcity of the antibodies for the interactions.
The transcriptional regulation activity of LMO2 has been
detected by using reporter genes containing either the E-box
motif (31,32) or Gal4-binding sequences in which LMO2 was
a fusion protein with Gal4-BD domain (33). In order to exam-
ine whether the interaction between LMO2 and hBex2 affects
the transcriptional activity of LMO2, we performed the luci-
ferase reporter gene assay using the Gal4 system (25,33).
cDNA plasmids for GFP-hBex2 and Gal4-BD-LMO2 were
cotransfected into Cos-7 cells together with a plasmid for
luciferase reporter gene driven by Gal4-binding enhancer.
GFP-hBex2 alone had no effect on the luciferase activity
(Figure 5A, column 3), while LMO2 activated the expression
of the reporter gene (Figure 5A, column 4). When hBex2 and
LMO2 were coexpressed, the luciferase activity was signiﬁc-
antly increased compared with that in LMO2 expression alone
(Figure 5A, column 6). The hBex2-mediated up-regulation
Figure 4. hBex2 is part of a complex with LMO2 that recognizes the E-box element. (A) EMSAs were performed with the g
32-ATP-labeled oligonucleotides of the
E-boxsequenceusingthenuclearextractfromM17cells.Labeledprobewasincubatedwithnuclearextractfor20minatroomtemperature(lanes2–4),thenfurther
incubatedwithpre-immuneserum(lane2),anti-LMO2anti-serum(lane3)oranti-hBex2anti-serum(lane4).Thesuper-shift bandandbind-shift bandareindicated
byarrows.(B)Thespecificityoftheformationofbind-shiftbandandsuper-shiftbandbyinteractionbetweenhBex2proteinanditsantibody.PurifiedhBex2protein
wasaddedintothebindingassaytocompetewiththeanti-hBex2Absasfollows:0mg(lane3),10mg(lane4),20mg(lane5),50mg(lane6)and100mg(lane7).The
competitive binding of the recombinant hBex2 reduced the intensity of both the bind-shift band and the super-shift band.
6560 Nucleic Acids Research, 2005, Vol. 33, No. 20of GAL4-BD-LMO2-dependent luciferase activity also
correlates with the amount of hBex2 cDNA used in transfec-
tion (Figure 5B).
LMO2 interacts with NSCL1 and NSCL2
To further elucidate the mechanisms by which hBex2 regulates
LMO2 function at the transcriptional level, we examined the
interaction of LMO2 with class II bHLH proteins during the
formation of a DNA-binding complex. There are two class II
bHLH proteins, SCL (also known as TAL-1) and NSCL1,
which are known to interact with LMO2 (25,29). Interestingly,
LMO2 interacts with the brain speciﬁc SCL homologue
NSCL1, but showed no effect on their transcriptional activity
(25). To test whether LMO2 interacts with NSCL2,aNSCL1
homolog with high sequence similarity (34,35) that regulates
its transcriptional function, we performed a mammalian two-
hybrid assay. Both pGAL4-BD-LMO2 and pV16-NSCL2
fusion proteins were expressed in HeLa cells to examine
their interaction as indicated by luciferase activity. As a con-
trol, pPM3-LMO2 and pVP16-NSCL1 were coexpressed and
were found to induce luciferase activity, consistent with the
previous report of their interaction (25) (Figure 6, column 5).
Coexpression of GAL4-BD-LMO2 and VP16-NSCL2 signiﬁc-
antly activated transcription of the reporter gene. This indic-
ates that NSCL2 is also a binding partner for LMO2
(Figure 6, column 6). To test if NSCL2 is part of the complex
of hBex2 and LMO2 in vivo, we performed coimmunoprecip-
itation with human fetal brain tissue. As shown in Figure 7A–
C, NSCL2 was coexpressed and coimmunoprecipitated with
hBex2 and LMO2 in human fetal brain extracts.
hBex2 influences the transcriptional activity of
LMO2 and NSCL2
To further explore the physiological relevance of the inter-
action between LMO2 and NSCL2, and the potential
regulatory role of hBex2 on the LMO2–NSCL2 complex, we
generated a reporter construct containing three tandem
repeated E-boxes adjacent to the ﬁreﬂy luciferase gene. In
the absence of NSCL2, neither LMO2 alone, nor the coexpres-
sion ofhBex2 andLMO2,had anyeffect onthe basal luciferase
activity (Figure 7D, columns 3–4). NSCL2, but not NSCL1,
was able to activate transcription of the reporter gene
(Figure 7D, columns 5 and 8), consistent with the previous
report that NSCL1 was a relatively weak transcriptional activ-
ator (25). It has been reported that the enhancement or repres-
sion of class II bHLH proteins on transcriptional activity
depends on both the target genes and the cellular context
(32). Furthermore, LMO2 was able to up-regulate NSCL2’s
transcriptional activity (Figure 7D, column 10), but had no
Figure 5. hBex2 enhances the transcriptional activity of LMO2.( A) pEGFP-
hBex2 increases LMO2-induced luciferase activity in a mammalian GAL4
system. The reporter plasmid contains a GAL4-BD-binding motif within the
promotersequenceupstreamoftheluciferasegene,allowingthebindingofthe
LMO2-GAL4-BD chimeric protein. Cos-7 cells were transiently transfected
with pGAL-LUC (firefly luciferase reporter gene plasmid) and TK (renilla
luciferase expression plasmid) as reporter gene plasmids and expression gene
plasmidsincludingpM3-LMO2andpEGFP-hBex2.pM3andpEGPFwereused
as control vector DNAs. The transcriptional activity of the reporter gene was
measured by relative luciferase activity value, which is the value of firefly
luciferase activity divided by the value of renilla luciferase activity. All in-
dicated relative luciferase activity values represent the means of three inde-
pendent transfections, and error bars indicate the standard deviations. (B) The
effectofhBex2onLMO2activityiscorrelatedwiththeamountofhBex2cDNA
plasmid. Increased amounts of cDNA plasmids were used in the luciferase
system as indicated from 0 to 200 ng.
Figure 6. Functional analysis of interaction between LMO2 and NSCL1 or
NSCL2. A mammalian two-hybrid system was used to detect the protein–
protein interaction as indicated by luciferase activity assay. Cos-7 cells were
transientlytransfectedwithpGALLUCandTKasreporterplasmidsalongwith
expression plasmids as indicated. The interactions were measured by relative
luciferase activity. All experiments were repeated more than three times with
triplication for each experiment. Error bars indicate standard deviations.
Nucleic Acids Research, 2005, Vol. 33, No. 20 6561effect on NSCL1 (column 6). Importantly, coexpression of
hBex2 augmented LMO2’s effect on NSCL2 (column 11).
In contrast, expression of hBex2 alone (data not shown) or
together with LMO2 did not affect NSCL1-dependent tran-
scription (Figure 7D, column 7). This result suggests that
the ability of hBex2 to up-regulate the transcriptional activity
of NSCL2 may be mediated by LMO2 within the complex.
hBex2 complex contains NL1/CLIM2/LDB1
LDB1 is an important cofactor that is involved in the assembly
of multiprotein complexes through interacting with the LIM-
domain (hence LDB1—LIM domain-binding protein 1) (36).
To examine if LDB1 is part of the hBex2 complex in vivo,w e
again performed coimmunoprecipitation with human fetal
brain tissue. As shown in Figure 8A and B, both LDB1 and
hBex2 were coexpressed in human fetal brain extracts and
coimmunoprecipitated by either anti-hBex2 or anti-LDB1 anti-
body. Furthermore, we used antibodies to LDB1 and hBex2 for
immunoprecipitation and conﬁrmed that both LMO2 and
NSCL2 are part of the complex now composed of at least
hBex2, LMO2, NSCL2 and LDB1 (Figure 8C and D).
DISCUSSION
In this report, we have presented evidence supporting the
notion that human Bex2 (previously named human Bex1)
can speciﬁcally bind to LMO2 and regulate the transcriptional
activity of the E-box sequence-binding complex containing
LMO2, NSCL2 and LDB1. Using a yeast two-hybrid system,
we ﬁrst identiﬁed LMO2 as a binding partner of hBex2. The
interaction was characterized by both protein–protein interac-
tion in vitro and nuclear colocalization. Deletion mutation
analysis revealed that the interaction is a human Bex2 speciﬁc
regulatory mechanism. Immunoprecipitation experiments
with human fetal brain tissue further showed the interactions
among the three proteins. Using EMSA and luciferase activity
assay, we have demonstrated that hBex2 can physically inter-
act with LMO2 and enhances its transcriptional activity
through the formation of an E-box-binding complex. We fur-
ther examined the interaction of LMO2 with the neuronal
bHLH protein, NSCL2, and ﬁrst showed that NSCL2 serves
as functional binding partner for LMO2. Our work also sug-
gests that hBex2 is able to augment the transcriptional activity
of the target gene upon expression of all three proteins in vitro.
Thus, hBex2 may act as a transcriptional regulator to modulate
the activityofLMO2and NSCL2,which play an important role
in embryonic development.
Functional interaction between hBex2 and LMO2
The interaction of hBex2 with LIM domain-only protein,
LMO2, was demonstrated in four independent assays: yeast
two-hybrid analysis, in vitro afﬁnity chromatography, nuclear
colocalization and immunoprecipitation in vivo. As a ‘bridge
molecule’, LMO2 plays a role in transcriptional regulation
through its interaction with other proteins as a DNA-
binding complex. There are two possible consequences of a
directinteractionbetweenhBex2 andLMO2.OneisthathBex2
inhibits LMO2 from binding to other proteins. The second is
that hBex2 facilitates the formation of an LMO2-containing
protein complex. Our EMSA experiment supports the latter
D
C
B
A
Figure 7. hBex2regulatesNSCL2activitythroughformationoftranscriptional
complex.(A)EndogenousexpressionofNSCL2inhumanfetalbraintoconfirm
the specificity of its polyclonal antibody. (B and C) Interaction of hBex2 and
LMO2 with NSCL2, respectively, in human fetal brain tissue. The fetal brain
tissue wasused to immunoprecipitatethe hBex2(B)or LMO2(C)withspecific
polyclonal Abs. Precipitate was blotted with anti-NSCL2 Ab. (D) hBex2 reg-
ulates E-box-dependent gene expression through LMO2 and NSCL2. The re-
porter system used here contains three tandem repeat sequences of wild-type
E-boxmotifadjacenttothefireflyluciferase.Themutantreportergenecontains
an inactive form of E-box motif as a control. Cos-7 cells were transiently
transfected with reporter gene plasmids along with expression plasmids as
indicated. A renilla luciferase plasmid was cotransfected in each transfection
to evaluate transfection efficiency. All experiments were repeated more than
three times with triplication for each experiment. Error bars indicate standard
deviations.
6562 Nucleic Acids Research, 2005, Vol. 33, No. 20possibility (Figure 4). Furthermore, hBex2 up-regulates
transcriptional activity of LMO2 through protein–protein
interaction (Figure 5). Our work has further unveiled a
novel binding partner for LMO2, NSCL2. hBex2 augmented
NSCL2-dependent transcriptional activity, presumably
through interacting with LMO2 (Figure 7). LMO2 contains
two transactive domains in both the N- and C-terminus as
well as two repressive LIM domains. The mechanisms by
which hBex2 up-regulates LMO2 transcriptional activity
may be a result of inhibiting the transcriptional activity of
the complex through blocking both repressive LIM domains
of LMO2, although our attempt in mapping the binding
domain within LMO2 did not yield any conclusive information
(data not shown).
Relevance of the novel LMO2 complex in
neuronal function
Studies on the interaction between LMO2 and SCL in hema-
topoiesis has implicated a functional role of bHLH proteins in
the LIM-modulation system (32,37). Since both hBex2 and
LMO2 are expressed in areas of the brain where SCL is not
detected, NSCL1 and NSCL2 became natural candidate bHLH
proteins to examine their participation in the binding complex
for the E-box motif (34,38,39). We have shown that LMO2
does not affect NSCL1-dependent transcription, consistent
with a previous ﬁnding (25). However, we cannot exclude a
potential regulatory role of NSCL1 in an LMO2 complex. The
interaction between LMO2 and NSCL2 reported here suggests
a neuronal-speciﬁc regulatory mechanism mediated by LMO2
and its binding partners. Furthermore, our work and that of
others also provide evidence indicating a potential role for
hBex2 complex in neurodevelopment. This evidence includes
the high expression of hBex2, LMO2 and NSCL2 in brain; fetal
brain tissue-derived yeast two-hybrid system used for detect-
ing their interaction; and demonstration of interaction in vivo
with human fetal brain tissue. However, further investigation
should be performed to determine whether these proteins are
colocalized in the same region or are differentiating neurons in
embryonic brain tissue.
Nuclear translocation of hBex2 and its function
Consistent with bioinformatics predictions and physiological
function, our study suggests that hBex2 is localized to the
nucleus in order to play a role in transcriptional regulation.
Interestingly, previous work has suggested that members of
Bex family may differ in their translocation between the cyto-
plasm and nucleus. For example, the interaction between Bex
and OMP may induce the nuclear localization of Bex (11). The
overexpression of human Bex2 in HEK293 cells has shown a
cytoplasmic localization pattern (8). The discrepancy between
our work and this reported result may be due to the use of
different cell lines. Future work on subcellular localization of
hBex2 in neuronal tissue would be helpful to clarify this issue.
In the case of hBex3 or NADE, it is predominantly distributed
in the cytoplasm for its role in the P75NTR signaling pathway
(5). It has been suggested that the protein translocation of Bex3
from the nucleus to the cytosol is required for this function (5).
This translocation is determined by a NES motif, although
mechanisms of regulating the subcellular trafﬁcking remain
elusive (5).
Finally, our study supports a working model in which hBex2
regulates the transcriptional activity of oligomeric DNA-
binding complex containing LMO2 and NSCL2 (Figure 9).
We suggest that human Bex2 binds to LMO2 as part of the
oligomeric complex that binds to the E-box motif-containing
sequence. This interaction may regulate the transcriptional
activity of LMO2 through its binding to NSCL2 within
the DNA-binding complex. The stoichiometry of the complex
is unknown, but the E-box-binding modules of the oligo-
meric complex are provided by at least one NSCL2
molecule. Another half of an E-motif-binding protein could
be either NSCL2 or another closely related bHLH protein.
Figure 8. Interaction of LDB1 with hBex2 mediated complex in vivo. Coimmunoprecipitation was performed using nuclear extracts from 4-month-old human fetal
brain. Antibodies against either LDB1 (A)o rhBex2 (B) were used to precipitate the protein complex, followed by western blotting conversely with two antibodies.
Similar coimmunoprecipitation was performed to confirm the interaction of LMO2 (C)o rNSCL2 (D) with LDB1 and hBex2.
Nucleic Acids Research, 2005, Vol. 33, No. 20 6563Therefore, the complex containing hBex2, LMO2, NSCL2 and
LDB1 will be formed at the E-box site to regulate speciﬁc gene
expression.
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